CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer’s disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion. The gene discussed is NFKB1; the disease is early-onset autosomal dominant Alzheimer disease.